PDCD1 and neoplasm: The presence of an abundant T cell infiltrate and the expression of an IFNγ-signature, along with the expression of PD-1 and PD-L1, are additional favorable predictors of response to ICBs since they represent indicators of a pre-existing anti-tumor immunity [38].